EUVIMEDEUVIMED entdecken
Crossref

Regulatory T cell therapies at a translational crossroads

Frontiers Policy Labs

Frontiers · 03.07.2026

DOI: 10.25453/plabs.32896283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers, erschienen am 03.07.2026. Verfasst von Frontiers Policy Labs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prof Rita Carsetti, International Union of Immunological Societies, Germany, and Prof Michael Schmueck-Henneresse, University Health Network, Canada — Bringing tolerance-restoring Treg therapies to patients worldwide requires regulation, manufacturing, and reimbursement to evolve alongside the science. For a full article, please click here.

Schlagwörter

regulatory T cellsTreg therapytranslational medicineregulatory approvalcell therapy manufacturingreimbursementtolerance inductionautoimmunity

Zitieren

APA

Labs, F. P. (2026). Regulatory T cell therapies at a translational crossroads. Frontiers. https://doi.org/10.25453/plabs.32896283

Vancouver

Labs FP. Regulatory T cell therapies at a translational crossroads. Frontiers. 2026. doi:10.25453/plabs.32896283

BibTeX
@article{Labs2026,
  author = {Labs, Frontiers Policy},
  title = {Regulatory T cell therapies at a translational crossroads},
  journal = {Frontiers},
  year = {2026},
  doi = {10.25453/plabs.32896283}
}
Kostenlos starten →